---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-181966"
form_type: "8-K"
ticker: "TCRT"
cik: "0001107421"
company_name: "Alaunos Therapeutics, Inc."
filed_at: "2023-07-05T23:59:59+00:00"
generated_at: "2026-06-13T12:30:43.407607+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Alaunos Therapeutics transfers to Nasdaq Capital Market; gets 180-day bid price extension to Jan 2, 2024

## Summary
- Transfer of Common Stock listing from Nasdaq Global Select to Capital Market approved July 5, effective July 7, 2023.
- Company granted additional 180 calendar days until January 2, 2024 to regain $1.00 minimum bid price compliance.
- Alaunos intends to consider a reverse stock split if necessary to cure the bid price deficiency.
- No assurance the company will regain compliance or meet other Nasdaq listing criteria.
- Common stock continues to trade under symbol TCRT on the Capital Market.

## SEC filing metadata
- accession: 0001193125-23-181966
- form_type: 8-K
- ticker: TCRT
- cik: 0001107421
- company_name: Alaunos Therapeutics, Inc.
- filed_at: 2023-07-05T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1107421/000119312523181966/0001193125-23-181966-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1107421/000119312523181966/d526439d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-181966
- JSON: https://secwatch.observer/filing/0001193125-23-181966.json
- Plain text: https://secwatch.observer/filing/0001193125-23-181966.txt

## Key facts
- Listing & Compliance Notices
  Alaunos Therapeutics, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: extension granted
  - Deficiency: minimum bid price
  - Rules: 5450(a)(1), 5810(c)(3)(A)
  source text: July 5, 2023, Nasdaq notified the Company that the Transfer was approved, and that, in connection with the Transfer, the Company was eligible for an additional 180 calendar day period, or until January 2, 2024 (the “Extended Compliance Date”), to regain compliance with the Bid Price Requirement. Effective at the opening of business on July 7, 2023, the Common Stock will be transferred to the Nasdaq Capital Market. The Common Stock will continue to trade under the symbol “TCRT.” The Nasdaq Capital Market operates in substantially the same manner as the Nasdaq Global Select Market, but with less
  evidence_url: https://www.sec.gov/Archives/edgar/data/1107421/000119312523181966/0001193125-23-181966-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.